Back

Pharmacogenomic diversity in psychiatry: Challenges and Opportunities in Africa

2024-01-17 pharmacology and therapeutics Title + abstract only
View on medRxiv
Show abstract

Pharmacogenomic studies on psychiatric drugs have slowly identified genetic variations that influence drug metabolism and treatment effectiveness in patients with mental illness. However, most of these studies have predominantly centered on people of European descent, leaving a substantial knowledge gap on the clinical implications of current pharmacogenomic evidence in multi-ancestry populations such as Africans. Thus, whether pharmacogenomic (PGx) genetic testing implemented in European popula...

Predicted journal destinations

1
Clinical Pharmacology & Therapeutics
19 training papers
Top 0.1% 15.0%
2
PLOS ONE
1737 training papers
Top 52% 12.1%
3
Frontiers in Pharmacology
27 training papers
#1 12.1%
4
British Journal of Clinical Pharmacology
21 training papers
Top 0.2% 8.0%
5
Scientific Reports
701 training papers
Top 36% 6.6%
6
Translational Psychiatry
94 training papers
Top 4% 5.7%
7
Frontiers in Psychiatry
56 training papers
Top 5% 2.9%
8
PLOS Medicine
95 training papers
Top 4% 2.0%
9
Brain, Behavior, and Immunity
35 training papers
Top 1.0% 1.9%
10
Genes
21 training papers
Top 2% 1.4%
11
Schizophrenia Bulletin
21 training papers
Top 4% 1.2%
12
BMC Psychiatry
20 training papers
Top 2% 1.2%
13
eBioMedicine
82 training papers
Top 6% 1.2%
14
Neuropsychopharmacology
29 training papers
Top 4% 1.0%
15
Journal of Affective Disorders
72 training papers
Top 7% 1.0%
16
JMIRx Med
29 training papers
Top 3% 1.0%
17
Antimicrobial Agents and Chemotherapy
17 training papers
Top 0.6% 1.0%
18
eLife
262 training papers
Top 44% 1.0%
19
The British Journal of Psychiatry
21 training papers
Top 4% 0.7%
20
BMC Medicine
155 training papers
Top 33% 0.7%
21
International Journal of Environmental Research and Public Health
116 training papers
Top 32% 0.7%
22
Nature Communications
483 training papers
Top 59% 0.7%
23
PLOS Global Public Health
287 training papers
Top 38% 0.5%